Wall Street brokerages expect that Acadia Healthcare Company Inc (NASDAQ:ACHC) will post $743.05 million in sales for the current quarter, according to Zacks Investment Research . Eight analysts have made estimates for Acadia Healthcare’s earnings. The highest sales estimate is $764.40 million and the lowest is $731.22 million. Acadia Healthcare posted sales of $724.51 million during the same quarter last year, which would indicate a positive year over year growth rate of 2.6%. The company is expected to announce its next earnings results on Wednesday, February 20th.
On average, analysts expect that Acadia Healthcare will report full year sales of $3.01 billion for the current financial year, with estimates ranging from $3.00 billion to $3.03 billion. For the next year, analysts anticipate that the business will report sales of $3.18 billion, with estimates ranging from $3.08 billion to $3.28 billion. Zacks’ sales calculations are a mean average based on a survey of research analysts that cover Acadia Healthcare.
Get Acadia Healthcare alerts: Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Monday, November 5th. The company reported $0.55 EPS for the quarter, missing the Zacks’ consensus estimate of $0.64 by ($0.09). Acadia Healthcare had a net margin of 7.43% and a return on equity of 7.71%. The business had revenue of $760.90 million for the quarter, compared to analysts’ expectations of $760.46 million. During the same period in the previous year, the business posted $0.58 earnings per share. The business’s revenue was up 6.2% compared to the same quarter last year.
ACHC has been the topic of a number of recent analyst reports. BidaskClub downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Wednesday, September 19th. Mizuho set a $37.00 price target on Acadia Healthcare and gave the stock a “hold” rating in a research note on Thursday, October 18th. Cantor Fitzgerald restated a “hold” rating and set a $39.00 price objective on shares of Acadia Healthcare in a report on Thursday, October 18th. Craig Hallum downgraded Acadia Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, October 17th. They noted that the move was a valuation call. Finally, Citigroup dropped their price objective on Acadia Healthcare from $46.00 to $43.00 and set a “buy” rating for the company in a report on Wednesday, November 14th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $41.00.
Shares of NASDAQ:ACHC traded up $0.51 during trading on Wednesday, reaching $27.50. 1,079,182 shares of the company were exchanged, compared to its average volume of 1,140,680. The firm has a market cap of $2.31 billion, a PE ratio of 12.02, a price-to-earnings-growth ratio of 1.23 and a beta of 0.53. Acadia Healthcare has a 12-month low of $24.27 and a 12-month high of $45.35. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.26 and a current ratio of 1.26.
In related news, Director Reeve B. Waud sold 41,865 shares of the firm’s stock in a transaction on Thursday, November 1st. The stock was sold at an average price of $45.00, for a total value of $1,883,925.00. Following the completion of the sale, the director now owns 14,213 shares of the company’s stock, valued at $639,585. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink . Corporate insiders own 2.50% of the company’s stock.
A number of hedge funds have recently made changes to their positions in ACHC. Cumberland Advisors Inc. bought a new position in Acadia Healthcare in the 4th quarter worth approximately $593,000. State Treasurer State of Michigan boosted its holdings in Acadia Healthcare by 7.9% in the third quarter. State Treasurer State of Michigan now owns 32,600 shares of the company’s stock worth $1,148,000 after acquiring an additional 2,400 shares in the last quarter. Strs Ohio acquired a new stake in Acadia Healthcare in the third quarter worth about $308,000. American International Group Inc. boosted its holdings in Acadia Healthcare by 8.6% in the third quarter. American International Group Inc. now owns 179,412 shares of the company’s stock worth $6,315,000 after acquiring an additional 14,175 shares in the last quarter. Finally, Public Employees Retirement System of Ohio boosted its holdings in Acadia Healthcare by 18.5% in the second quarter. Public Employees Retirement System of Ohio now owns 36,925 shares of the company’s stock worth $1,511,000 after acquiring an additional 5,762 shares in the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
Recommended Story: How does a reverse stock split work?
Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter .